Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893397 · ClinicalTrials.gov registry record · NA
Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer
A NA study of Malignant Bone Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT02893397: Active NA study of Malignant Bone Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT02893397 is a NA study of Malignant Bone Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02893397, a NA study of Malignant Bone Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies how well supervised exercise works in improving physical fitness before surgery in patients with bone cancer that can be removed by surgery. Supervised exercise may provide better short-term physical fitness in patients with bone cancer.
Primary Outcome
Completion of daily exercise is defined as at least 20 minutes of aerobic exercise achieved within heart rate and blood pressure that the licensed physical therapist has determined is safe for the patient on that given day.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Intervention
- DEVICE Activity Monitor
Study Locations (2)
Texas
- M D Anderson Cancer Center - Houston
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-08-30 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What the registry record for NCT02893397 still lists
NCT02893397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Malignant Bone Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Exercise Intervention is the first listed.
NCT02893397 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02893397 about?
NCT02893397 is a clinical study titled "Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer". This clinical trial studies how well supervised exercise works in improving physical fitness before surgery in patients with bone cancer that can be removed by surgery. Supervised exercise may provide better short-term physical fitness in patients with bone cancer.
What is the current status of trial NCT02893397?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2016-08-30. Estimated completion is 2026-08-30.
What conditions does trial NCT02893397 study?
This clinical trial studies the following conditions: Malignant Bone Neoplasm.
What interventions are being tested in trial NCT02893397?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL), Activity Monitor (DEVICE).
Who is sponsoring clinical trial NCT02893397?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02893397 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02893397's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI